Brief: Bafna Pharmaceuticals approves withdrawal of preferential issue of 4 mln share warrants
04/01/2017 12:58
Jan 4 (Reuters) - Bafna Pharmaceuticals Ltd BAFP.NS :
* says approved withdrawal of preferential issue of 4
million earnings per share warrants
Source text: (http://bit.ly/2j8E6wG)
Further company coverage: BAFP.NS
(Bengaluru newsroom)
((Reuters Messaging: Bangalore.newsroom@thomsonreuters.com))
Recent news on BAFNA Pharmaceuticals
See all newsBrief: Bafna Pharmaceuticals Says Commercial Production At Co's Manufacturing Facilities In Chennai, Tamil Nadu Started
Brief: Bafna Pharmaceuticals Says Due To Torrential Rains of Michaung Cyclone, Co's Manufacturing Facilities In Chennai Was Totally Flooded
Brief: India's Bafna Pharmaceuticals Dec-Qtr Net PAT Rises
Brief: Bafna Pharmaceuticals Says Approved Fund Raise By Issue Of Shares
To Consider Proposal For Various Avenues For Raising Funds